
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.960 | 5.960 | 0.000 |
Shares | 94.040 | 94.040 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 31.077 | 16.086 |
Price to Book | 8.878 | 2.678 |
Price to Sales | 9.017 | 2.073 |
Price to Cash Flow | 24.341 | 10.339 |
Dividend Yield | 0.403 | 2.803 |
5 Years Earnings Growth | 16.281 | 11.902 |
Name | Net % | Category Average |
---|---|---|
Technology | 39.950 | 20.134 |
Financial Services | 19.630 | 20.185 |
Healthcare | 14.000 | 12.795 |
Communication Services | 9.730 | 9.306 |
Consumer Cyclical | 9.100 | 12.278 |
Industrials | 7.580 | 13.946 |
Number of long holdings: 23
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 7.17 | 111.01 | +4.30% | |
Netflix | US64110L1061 | 7.09 | 1,101.53 | +0.42% | |
ASML ADR | USN070592100 | 6.81 | 677.27 | +0.34% | |
Visa A | US92826C8394 | 5.74 | 335.17 | -0.16% | |
Intuit | US4612021034 | 4.91 | 624.12 | +1.51% | |
Synopsys | US8716071076 | 4.78 | 446.62 | +1.76% | |
Airbnb | US0090661010 | 4.74 | 122.51 | +0.66% | |
S&P Global | US78409V1044 | 4.56 | 480.00 | -0.26% | |
Eli Lilly | US5324571083 | 4.44 | 884.54 | +2.89% | |
Intuitive Surgical | US46120E6023 | 4.39 | 514.59 | +1.27% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bellevues Lux BB Adamant Medtech HB | 1.38B | 2.19 | -1.22 | 6.95 | ||
Adamant Medtech B EUR | 1.38B | -1.00 | 2.00 | 8.81 | ||
Adamant Medtech I EUR | 1.38B | -0.83 | 2.71 | 9.59 | ||
Adamant Medtech T EUR | 1.38B | -0.90 | 2.40 | 9.25 | ||
LU1477743386 | 317.81M | -3.21 | -3.38 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review